Skip to main content

Ototoxicity clinical trials at UCSD
1 research study open to eligible people

  • Treatment of Radiation and Cisplatin Induced Toxicities With Tempol

    open to eligible people ages 18 years and up

    A 10 week trial to assess the ability of Tempol to prevent and/or reduce toxicities associated with cisplatin and radiation treatment in head and neck cancer patients. Over the course of the 10 week trial, mucositis, nephrotoxicity, and ototoxicity will be monitored and assessed.

    La Jolla, California and other locations

Last updated: